Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts Review uri icon

Overview

MeSH Major

  • 6-Mercaptopurine
  • Azathioprine
  • Colorectal Neoplasms
  • Folic Acid
  • Inflammatory Bowel Diseases
  • Mesalamine
  • Ursodeoxycholic Acid

abstract

  • Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review examines the most recent data on 5-aminosalicylate as a chemoprophylactic drug as well as ursodeoxycholic acid, folic acid, azathioprine, and 6-mercaptopurine.

publication date

  • October 2007

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/ibd.20186

PubMed ID

  • 17567870

Additional Document Info

start page

  • 1293

end page

  • 8

volume

  • 13

number

  • 10